Alex Sapir serves as Executive at Dova Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Alex Sapir has executed 6 insider transactions totaling $1.3M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 3, 2024 involved exercising options for 150,000 shares valued at $490.5K.
Alex Sapir currently holds 193,360 shares of Dova Pharmaceuticals, Inc. (DOVA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Alex Sapir has been a net buyer of DOVA stock. They have purchased $1.3M and sold $0 worth of shares.
Alex Sapir's most recent insider trade was on Jul 3, 2024, when they sold 150,000 shares at $3.27 per share.
Get notified when new Form 4 filings are submitted
| $11.35 |
| Discretionary |
| May 19, 2023 | PHAS | $0 | Option Exercise | 3,750 | $N/A | Discretionary |
| Aug 14, 2018 | DOVA | $495.4K | Purchase | 21,700 | $22.83 | Discretionary |
| Dec 22, 2017 | DOVA | $100.0K | Option Exercise | 26,809 | $3.73 | Discretionary |
| Jul 5, 2017 | DOVA | $341.7K | Purchase | 20,100 | $17.00 | Discretionary |